A monthly recap of the latest news about Alzheimer’s and dementia Nearly half of dementia cases are preventable The 2024 Lancet dementia report identified 14 key risk factors, plus two new ones, suggesting that 45 percent of dementia cases could be preventable with lifelong intervention. Read here. TDP-43 function is lost a decade
A monthly recap of the latest news about Alzheimer’s and dementia Personalized health coaching may improve cognition and lower dementia risks in some older adults A personalized dementia risk reduction intervention modestly improved cognition and reduced dementia risk factors in older adults at high risk for the condition, according to an NIA-funded study. Read more.
A monthly recap of the latest news about Alzheimer’s and dementia 7 Things to Know About New Alzheimer’s Drug Kisunla A new drug for Alzheimer’s was just this month approved by the FDA for use in the United States, in people in the earliest stages of the disease. Read More. Blood test accurately diagnosed Alzheimer’s
A monthly recap of the latest news about Alzheimer’s and dementia Study on caregivers finds brief bouts of lucidity are common among people with dementia By conducting in-depth interviews with family caregivers of people with severe dementia, researchers have documented how many of those caregivers witnessed paradoxical lucidity, an unexpected return of mental clarity in
A monthly recap of the latest news about Alzheimer’s and dementia Mediterranean staple may lower your risk of death from dementia, study finds A daily spoonful of olive oil could lower your risk of dying from dementia, according to a new study by Harvard scientists. Read more. Study defines major genetic form of
A monthly recap of the latest news about Alzheimer’s and dementia Following the MIND diet may help slow aging and lower dementia risk, study shows New research suggests that following an eating plan called the MIND diet may slow down biological aging. Read more here. Disruption of a molecular pathway may be involved in
Learn more about the Alzheimer's drug Lecanemab (marketed as Leqembi), which just received accelerated approval from the FDA. Watch Alzheimer's Orange County CEO, Jim McAleer and CMO of Irvine Clinical Research, Dr. Trinh explain the science behind the new Alzheimer's drug and how it works. *Video recorded on December 2022 prior to the
Alzheimer's Orange County Board Member, Dr. Dung Trinh and President and CEO, Jim McAleer discuss recent Alzheimer's disease breakthroughs and research updates in this entry of the "Health Talks with Dr. Trinh" series airing on OC Talk Radio. Watch the full interview below.
Brought to you by: “An ounce of prevention is worth a pound of cure.” - Benjamin Franklin It’s easier to solve a problem if you know the cause. In medicine this means understanding why people get sick and treating the disease itself, not just the symptoms. For nearly 100 years, the medical community had
Brough to you by the ASPECT™ clinical research study Alzheimer’s dementia is most commonly associated with memory loss, but this form of dementia causes other significant symptoms as well. One of the most prevalent of these symptoms is agitation. If you care for someone with agitation associated with Alzheimer’s dementia, you understand the challenges involved
